[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1748 

# __Lack of vaccine or cure__

## Category to which it belongs

* [The challenges in vaccination include limited storage capacity, high patient demand, inefficient resource use, distribution difficulties, waning vaccine effectiveness, and unequal access.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_103.md)

## Closest similar item

* [Lack of drugs and vaccines](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1349.md)
* [Lack of knowledge about the virus, treatments, and vaccines](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2920.md)
* [Lack of COVID-19 vaccine](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2303.md)
* [Lack of vaccines and agent-specific drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1540.md)
* [Lack of immunity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2771.md)
* [Vaccine hesitancy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1909.md)
* [Inadequate vaccine efficacy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1911.md)
* [Lack of medication and vaccines for COVID-19](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1495.md)
* [Vaccine availability, Vaccine hesitancy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3168.md)
* [Inadequate vaccination coverage](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3239.md)

## Description of the risk

Currently, there is no standard vaccine or cure for the virus

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Type of the risk

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_2.md)

## Mitigations of this risk

* [Support research and development of vaccine and antiviral treatments, promote preventive measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2316.md)

## Name of the risk

High risk of severe illness and death for infected individuals

## Stakeholders who can mitigate this risk

* [pharmaceutical companies](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_124.md)
* [research institutions](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_413.md)

## Articles mentionning the risk

* [Role of Information Technology in Covid-19 Prevention](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_267.md)

## People affected by this risk

* [healthcare workers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_68.md)
* [general population](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_9.md)

## Technologies linked to the risk

* [research and development](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_269.md)
* [public health measures](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1030.md)

## Property: has_RiskType

* [technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)
* [economic](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_3.md)

